| Basic Information |
■ Research Fields
| Hematology and medical oncology, Parasitology
|
|
| Academic Achievements |
■ Selected Publications
|
1. |
2024/03 |
Article |
Antibody responses to multiple doses of the mRNA-1273 COVID-19 vaccine (Moderna) in staff of a health science university in Japan Journal of Kumamoto Health Science University pp.13-24 (Collaboration) |
|
2. |
2023/11 |
Article |
A longitudinal analysis of paroxysmal nocturnal haemoglobinuria- type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. Br J Haematol 203(3),pp.468-476 (Collaboration) |
|
3. |
2023/11 |
Article |
Management and risk factors for pleural effusion in Japanese patients with chronic myeloid leukemia treated with first-line dasatinib in real-world clinical practice. Intern Med 62(22),pp.3299-3303 (Collaboration) |
|
4. |
2023/10 |
Article |
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan. Int J Hematol 118(4),pp.419-431 (Collaboration) |
|
5. |
2023/08 |
Article |
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. Int J Hematol 118(2),pp.210-220 (Collaboration) |
|
6. |
2023/05 |
Article |
Helicobacter kumamotonensis sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 73(3) (Collaboration) |
|
7. |
2023/03 |
Article |
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML. Cancer Sci 114(3),pp.995-1006 (Collaboration) |
|
8. |
2022/12 |
Article |
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors. Ann Med 54(1),pp.1244-1254 (Collaboration) |
|
9. |
2022/05 |
Article |
A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result. J Infect Chemother 28(5),pp.669-677 (Collaboration) |
|
10. |
2022/04 |
Article |
Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan. Int J Hematol 115(4),pp.470-480 (Collaboration) |
|
11. |
2021/08 |
Article |
The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure. Ann Hematol 100(8),pp.1975-1982 (Collaboration) |
|
12. |
2021/01 |
Article |
Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs. J Infect Chemother 27(1),pp.1-6 (Collaboration) |
|
13. |
2020/12 |
Article |
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort. Cancer Med 9(23),pp.8931-8939 (Collaboration) |
|
14. |
2018/02 |
Article |
Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan. Int J Hematol 107(6),pp.656-665 (Collaboration) |
|
15. |
2018/02 |
Article |
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase. Med Oncol 35(3),pp.38 (Collaboration) |
|
16. |
2018/02 |
Article |
Isolated pancreatic myeloid sarcoma associated with t(8;21)/RUNX1-RUNX1T1 rearrangement. Intern Med 57(4),pp.563-568 (Collaboration) |
|
17. |
2017/01 |
Article |
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group. Leukemia Research 54,pp.55-58 (Collaboration) |
|
18. |
2017 |
Book |
Pathogenesis of cloncal dominance in PNH: Selection mechanism in PNH. Paroxysmal Nocturnal Hemoglobinuria. From Bench to Bedside(Eds. Kanakura Y et al.). 2017, Tokyo. pp.215-228 (Collaboration) |
|
Display 5 items
|
|
Display all(18)
|
|
